Bowhead Specialty (NYSE:BOW) Raised to Hold at Zacks Research

Bowhead Specialty (NYSE:BOWGet Free Report) was upgraded by stock analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a note issued to investors on Tuesday,Zacks.com reports.

Several other brokerages have also recently weighed in on BOW. Morgan Stanley decreased their price target on Bowhead Specialty from $31.00 to $29.00 and set an “equal weight” rating for the company in a research note on Monday, November 17th. Weiss Ratings reissued a “hold (c-)” rating on shares of Bowhead Specialty in a research report on Monday, December 29th. Royal Bank Of Canada lowered their price target on shares of Bowhead Specialty from $33.00 to $30.00 and set an “outperform” rating for the company in a report on Wednesday. Piper Sandler upped their price objective on shares of Bowhead Specialty from $30.00 to $32.00 and gave the company an “overweight” rating in a research note on Monday, December 22nd. Finally, Keefe, Bruyette & Woods decreased their price objective on shares of Bowhead Specialty from $38.00 to $36.00 and set an “outperform” rating for the company in a research report on Tuesday, January 6th. Five analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $33.33.

View Our Latest Stock Analysis on Bowhead Specialty

Bowhead Specialty Stock Performance

Shares of NYSE:BOW opened at $25.99 on Tuesday. The firm has a market cap of $851.85 million, a PE ratio of 16.34, a price-to-earnings-growth ratio of 0.77 and a beta of -1.05. The firm’s fifty day moving average is $25.79 and its 200-day moving average is $26.99. Bowhead Specialty has a 52 week low of $22.15 and a 52 week high of $42.29.

Bowhead Specialty (NYSE:BOWGet Free Report) last posted its quarterly earnings data on Tuesday, February 24th. The company reported $0.47 earnings per share for the quarter, beating analysts’ consensus estimates of $0.45 by $0.02. The business had revenue of $151.68 million during the quarter, compared to the consensus estimate of $145.99 million. Bowhead Specialty had a return on equity of 13.58% and a net margin of 9.75%. Sell-side analysts forecast that Bowhead Specialty will post 1.36 EPS for the current year.

Institutional Trading of Bowhead Specialty

Several large investors have recently modified their holdings of BOW. Invesco Ltd. lifted its position in shares of Bowhead Specialty by 3.5% during the 4th quarter. Invesco Ltd. now owns 14,484 shares of the company’s stock valued at $413,000 after acquiring an additional 490 shares during the period. Susquehanna Fundamental Investments LLC grew its holdings in Bowhead Specialty by 21.7% in the fourth quarter. Susquehanna Fundamental Investments LLC now owns 39,346 shares of the company’s stock worth $1,123,000 after purchasing an additional 7,005 shares during the period. Interval Partners LP bought a new stake in Bowhead Specialty in the fourth quarter valued at $950,000. Balyasny Asset Management L.P. increased its stake in Bowhead Specialty by 122.2% in the fourth quarter. Balyasny Asset Management L.P. now owns 251,893 shares of the company’s stock valued at $7,189,000 after purchasing an additional 138,524 shares in the last quarter. Finally, Schonfeld Strategic Advisors LLC raised its holdings in shares of Bowhead Specialty by 19.6% during the fourth quarter. Schonfeld Strategic Advisors LLC now owns 70,926 shares of the company’s stock valued at $2,024,000 after purchasing an additional 11,640 shares during the period.

Key Headlines Impacting Bowhead Specialty

Here are the key news stories impacting Bowhead Specialty this week:

  • Positive Sentiment: Q4 results beat consensus on the headline figures: revenue and EPS topped estimates, gross written premiums and net income grew, and Bowhead reported strong GWP growth for Q4/FY2025 — a clear fundamental catalyst for investor buying. Business Wire: Q4 & FY2025 Results
  • Positive Sentiment: Management gave growth color for 2026 — expecting roughly 20% premium growth and acceleration of digital underwriting — which supports revenue trajectory and margin leverage expectations. MSN: 20% Premium Growth Guidance
  • Positive Sentiment: Short interest declined materially in February (down ~26.9% vs. late January), lowering the short-interest ratio to about 3.9 days. Reduced short exposure can amplify upward moves as bears cover. (Short-interest data reported 789,713 shares short as of Feb. 13.)
  • Neutral Sentiment: Royal Bank of Canada trimmed its price target from $33 to $30 but kept an “outperform” rating — a mixed signal (lower upside vs. prior target, but continued buy-side endorsement). Benzinga: RBC price target
  • Negative Sentiment: There are conflicting transcript/coverage notes from the earnings call that some outlets flagged an EPS miss (rounded/adjusted figures differ across sources), which could cause short-term investor confusion or volatility as the market digests GAAP vs. adjusted metrics. InsiderMonkey: Q4 Earnings Call Transcript

About Bowhead Specialty

(Get Free Report)

Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.

Read More

Analyst Recommendations for Bowhead Specialty (NYSE:BOW)

Receive News & Ratings for Bowhead Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bowhead Specialty and related companies with MarketBeat.com's FREE daily email newsletter.